The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours--a prospective study
- PMID: 11534670
- DOI: 10.1007/s007010170058
The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours--a prospective study
Abstract
Objective: To analyze prospectively the frequency and the risk of symptomatic and asymptomatic haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours.
Methods: The study was conducted within a time frame of 24 months (April 1998-April 2000). 326 patients (150 males, 176 females; mean age 56.8 years) were included and 345 computerized tomography (CT)-guided stereotactic biopsies were performed/supervised by a specialized stereotactic neurosurgeon. A modified Riechert Stereotaxy System and a workstation for multiplanar trajectory planning were used in all patients. Serial biopsies (median, 5 samples) were done with small forceps (diameter 1 mm), smear preparations of the biopsy specimens were intra-operatively examined. Frequency, size, and location of any detectable bleeding were analyzed by post-biopsy CT-scan investigation. For risk estimation, logistic regression analysis was performed. The chi-square statistic was used for comparative analysis of the study results with available data from the literature.
Results: A conclusive tissue diagnosis could be achieved in 98%. Overall treatment morbidity was 3.1%. There was no mortality. Haemorrhage related morbidity was 0.9%. Age, Karnofsky score, mass effect of the tumour, tumour histology, tumour location and the number of specimens taken did not have any prognostic significance. The clinically silent bleeding rate was 9.6% and more often seen in patients with high grade gliomas (p = 0.03). Both the silent and non-silent bleeding rate were significantly lower as compared to available prospective data in the literature (p < 0.01).
Conclusion: Using multiplanar image guided trajectory planning, small biopsy forceps and intra-operative smear preparations the risk of major haemorrhage related morbidity after stereotactic brain tumour biopsy is extremely low (<1%) in experienced hands.
Similar articles
-
Hemorrhage after stereotactic biopsy from intra-axial brain lesions: incidence and avoidance.J Neurol Surg A Cent Eur Neurosurg. 2014 May;75(3):177-82. doi: 10.1055/s-0032-1325633. Epub 2013 Mar 22. J Neurol Surg A Cent Eur Neurosurg. 2014. PMID: 23526202
-
An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study.Surg Neurol. 2005;64 Suppl 2:S82-8. doi: 10.1016/j.surneu.2005.07.055. Surg Neurol. 2005. PMID: 16256850
-
Yield and complications of frame-based and frameless stereotactic brain biopsy--the value of intra-operative histological analysis.Br J Neurosurg. 2014 Oct;28(5):637-44. doi: 10.3109/02688697.2014.887657. Epub 2014 Feb 25. Br J Neurosurg. 2014. PMID: 24568533
-
Complications after frame-based stereotactic brain biopsy: a systematic review.Neurosurg Rev. 2021 Feb;44(1):301-307. doi: 10.1007/s10143-019-01234-w. Epub 2020 Jan 4. Neurosurg Rev. 2021. PMID: 31900737
-
Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis.J Neurooncol. 2021 Aug;154(1):1-11. doi: 10.1007/s11060-021-03785-9. Epub 2021 Jul 12. J Neurooncol. 2021. PMID: 34251602 Review.
Cited by
-
Treatment of glioblastoma in elderly patients.CNS Oncol. 2014 Mar;3(2):159-67. doi: 10.2217/cns.14.11. CNS Oncol. 2014. PMID: 25055021 Free PMC article.
-
Prognostic Value of Conventional Magnetic Resonance Imaging for Adult Patients with Brain Tumors.Clin Neuroradiol. 2015 Sep;25(3):281-9. doi: 10.1007/s00062-014-0309-3. Epub 2014 May 15. Clin Neuroradiol. 2015. PMID: 24828225 Clinical Trial.
-
A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Neuro Oncol. 2016 Jun;18(6):873-80. doi: 10.1093/neuonc/nov301. Epub 2015 Dec 19. Neuro Oncol. 2016. PMID: 26688076 Free PMC article.
-
The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.J Neurooncol. 2015 Dec;125(3):481-501. doi: 10.1007/s11060-015-1866-2. Epub 2015 Nov 3. J Neurooncol. 2015. PMID: 26530259
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous